Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

BCH-1393 stimulates CTL response in vitro and in vivo

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...